Hormonal Control of Urine Production and Diuretics

Overview of Body Fluid Regulation and Solute Balance

• Total Body Water (TBW) Distribution:     * Total body water constitutes approximately $60\%$ of total body weight.     * Intracellular Fluid (ICF): Accounting for $40\%$ of body weight ($\frac{2}{3}$ of TBW).     * Extracellular Fluid (ECF): Accounting for $20\%$ of body weight ($\frac{1}{3}$ of TBW).         * The ECF is further divided by the capillary wall into Interstitial Fluid and Plasma.

• Regulation of Solutes:     * Sodium salts are the most abundant solutes in the ECF, representing $90-95\%$ of all ECF solutes.     * Sodium ($Na^+$) is the only cation exerting significant osmotic pressure.     * Changes in plasma sodium levels directly affect:         * Plasma volume and blood pressure.         * Intracellular fluid (ICF) and interstitial fluid volumes.

Dynamics of Volume and Osmolarity Changes

• Isosmotic Volume Contraction:     * Example: Diarrhea or severe burns.     * Mechanism: Fluids and solutes are lost from plasma in proportional amounts; blood osmolarity does not change.     * Hematocrit (HCT): Increases because the same number of Red Blood Cells (RBCs) remains in a smaller volume of plasma.     * Protein Concentration: Increases because the same amount of protein exists in a smaller volume.

• Hyperosmotic Volume Contraction:     * Example: Sweating, Diabetes Insipidus, or dehydration.     * Mechanism: Sweat is hypo-osmotic; mostly water is lost while solutes are retained. Plasma volume declines but plasma osmolarity increases.     * Fluid Shift: Water moves out of the cells (ICF) to the ECF to balance solute concentration.     * Hematocrit (HCT): Does not change. While there are fewer total fluids, the cells crenate (shrink) due to water loss, balancing the ratio.     * Protein Concentration: Increases.

• Hypoosmotic Volume Contraction:     * Example: Adrenal insufficiency (Addison’s Disease) or abuse of diuretics.     * Mechanism: No aldosterone results in sodium and water being excreted at higher levels. Sodium loss from plasma is significant.     * Fluid Shift: Blood osmolarity is reduced; water moves from ECF into the RBCs.     * Hematocrit (HCT): Increases because Mean Corpuscular Volume (MCV) increases due to water gain.     * Protein Concentration: Increases.

• Isosmotic Volume Expansion:     * Example: Infusion of isosmotic $NaCl$ (saline).     * Mechanism: Isosmotic fluid is added to the plasma compartment.     * Hematocrit (HCT): Decreases due to dilution.     * Protein Concentration: Decreases.

• Hyperosmotic Volume Expansion:     * Example: High $NaCl$ intake, Conn’s disease, or Cushing’s syndrome.     * Mechanism: Excessive aldosterone leads to more sodium and water retention. Plasma osmolarity increases.     * Fluid Shift: Water moves from the cells (ICF) to the plasma (ECF) until equilibrium is reached; osmolarity for both compartments increases.     * Hematocrit (HCT): Decreased (more plasma volume and crenated cells).

• Hypoosmotic Volume Expansion:     * Example: SIADH (Syndrome of Inappropriate Antidiuretic Hormone).     * Mechanism: Excessive ADH leads to scant, concentrated urine and high water retention, reducing ECF osmolarity.     * Fluid Shift: Water moves into the cells until equilibrium is reached; osmolarity for both compartments decreases.     * Hematocrit (HCT): No change.     * Protein Concentration: Decreases.

Regulation of Sodium Balance

• Sympathetic Nerve Activity:     * Increases $Na^+$ reabsorption by the Proximal Convoluted Tubule (PCT).     * Afferent/Efferent constriction: Maintains normal Glomerular Filtration Rate (GFR) indirectly via the Renin-Angiotensin-Aldosterone (R-A-A) system if pressure decreases. Under severe pressure drops, it decreases GFR to retain water and sodium in the blood.

• R-A-A System: Promotes increased sodium reabsorption.

• Atriopeptin (ANP: Atrial Natriuretic Peptide): Increases GFR and decreases sodium reabsorption in response to high sodium intake or increased ECF volume.

• Effective Arterial Blood Volume (EABV): A decrease in EABV triggers sympathetic activity and the R-A-A system, while an increase triggers ANP and decreases sympathetic activity.

Regulation of Potassium ($K^+$) Balance

• Significance of Potassium:     * Hyperkalemia (high $K^+$) and Hypokalemia (low $K^+$) can disrupt electrical conduction in the heart, potentially leading to sudden death.

• Aldosterone Feedback: Increased $K^+$ in the ECF around the adrenal cortex triggers the release of aldosterone, which leads to $K^+$ secretion. Potassium thus controls its own concentration via negative feedback.

• Internal Potassium Balance Factors:     * The majority of potassium is found within cells ($ICF$). Small shifts out of the cell cause massive changes in $ECF$ concentration.     * Acid/Base Balance: $H^+$ and $K^+$ maintain electroneutrality. Hyperkalemia can lead to acidosis ($K^+$ moves in, $H^+$ moves out).     * Exercise: ATP depletion leads to increased permeability of $K^+$ (active hyperemia).     * Cell Lysis: Occurs in burns, rhabdomyolysis, and cancer chemotherapy, releasing intracellular $K^+$ into the ECF.

• Nephron Handling of Potassium:     * PCT: Approximately $65\%$ of potassium is reabsorbed.     * Loop of Henle: Approximately $27\%$ is reabsorbed.     * Late DCT (LDCT) and Collecting Ducts: Principal cells provide variable secretion to maintain levels based on dietary intake ($1-110\%$ excretion range).     * Low Potassium Diet: Leads to increased reabsorption of $K^+$ at the cost of secreting $H^+$ (can cause alkalosis).     * High Potassium Diet: Increases Na/K ATPase expression via aldosterone to increase secretion capacity.

Acid-Base Impact on Potassium Regulation

• Scenario 1: Acute Acidosis:     * $H^+$ ions enter the cells and $K^+$ leaves, resulting in hyperkalemia.     * While high $K^+$ usually triggers aldosterone, the high intracellular $[H^+]$ reduces the activity of the $Na^+/K^+$ pump, keeping plasma $[K^+]$ elevated.

• Scenario 2: Chronic Acidosis (lasting several days):     * Inhibits $NaCl$ and water reabsorption at the PCT.     * Leads to greater filtrate volume at the LDCT, which stimulates potassium secretion.     * This effect overrides the inhibitory effect of $H^+$ on the $Na^+/K^+$ ATPase, leading to a net loss of potassium.

Endocrine Disorders Review

• Conn’s Disease (Primary Aldosteronism):     * Excessive aldosterone production.     * Results in Hypernatremia (high sodium), Hypokalemia (low potassium), and Hypertension.

• Cushing’s Syndrome (Primary Hyperadrenalism):     * Excessive production of aldosterone, androgens, and glucocorticoids.     * Results in Hypernatremia, Hypokalemia, and Hypertension.     * High blood sugar levels (resembling Diabetes Mellitus) due to glucocorticoids.     * Masculinization due to increased androgen production.

• Addison’s Disease (Primary Adrenal Insufficiency):     * Deficiency in aldosterone and glucocorticoids.     * Results in Hypoaldosteronism, Low Blood Pressure, Hyponatremia (low sodium), and Hyperkalemia (high potassium).     * Mild acidosis occurs as $H^+$ exits cells while $K^+$ enters.     * Low blood sugar levels due to decreased glucocorticoids.

Hypertension and Diuretics

• Primary Hypertension: Unknown cause; symptoms treated with diuretics, ACE inhibitors, or calcium channel blockers (to reduce inotropy/contractility).

• Secondary Hypertension: Triggered by physiological events.     * Goldblatt (Renal) Hypertension: Renin is released inappropriately (e.g., due to blockage in renal artery or anorexia/low GFR). This leads to the R-A-A cascade, high blood pressure, and potentially congestive heart failure.

• Osmotic Diuretics (Mannitol):     * Location: Works at the PCT.     * Mechanism: A simple sugar freely filtered but not reabsorbed. It stays in the tubule lumen, creating obligatory water loss to maintain an osmolarity of $300\,mOsmolal$.

• Loop Diuretics (Furosemide/Lasix):     * Location: Thick ascending loop of Henle.     * Mechanism: Inhibits $Na^+K^+Cl^-$ transporters. This destroys the medullary interstitial gradient, causing water to remain in the lumen.     * Side Effects: Risk of hypokalemia, which can cause hyperpolarization of excitable cells.

• Thiazides:     * Location: Early Distal Convoluted Tubule (DCT).     * Mechanism: Inhibit $Na/Cl$ transporters, preventing salt reabsorption so water stays in the lumen.

• Spironolactone (Aldosterone Antagonist):     * Location: Late DCT/Collecting Tubules.     * Mechanism: Binds to aldosterone receptors, decreasing the number of $Na/K$ pumps on basolateral membranes. This blocks $NaCl$ reabsorption and $K^+$ secretion.     * Pros: Potassium-sparing; often used with Lasix.     * Cons: Can cause hyperkalemia and has anti-androgen effects (gynecomastia in men).

• Amiloride (Sodium Inhibitor):     * Location: Late DCT/Collecting Tubules.     * Mechanism: Blocks $Na^+$ channels on luminal membranes. Sodium is excreted and water follows.     * Pros: Potassium-sparing.

• Mnemonic for Diuretic Locations:     * "My Fun Teacher Adores Students"     * Mannitol (PCT), Furosemide (Loop), Thiazide (Early DCT), Amiloride (Late DCT/Collecting), Spironolactone (Late DCT/Collecting).

Diuretics Overview

• Mannitol

  • Location: Works at the PCT.

  • Mechanism: A simple sugar freely filtered but not reabsorbed, resulting in obligatory water loss to maintain an osmolarity of $300 \, mOsmolal$.

• Lasix (Furosemide)

  • Location: Thick ascending loop of Henle.

  • Mechanism: Inhibits $Na^+K^+Cl^-$ transporters, destroying the medullary interstitial gradient, causing water retention in the lumen.

  • Pros/Cons: Risk of hypokalemia, leading to hyperpolarization of excitable cells.

• Thiazides

  • Location: Early Distal Convoluted Tubule (DCT).

  • Mechanism: Inhibit $Na/Cl$ transporters preventing salt reabsorption, thus retaining water in the lumen.

• Spironolactone

  • Location: Late DCT/Collecting Tubules.

  • Mechanism: Aldosterone receptor antagonist, decreasing sodium reabsorption and potassium secretion; potassium-sparing effect.

• Amiloride

  • Location: Late DCT/Collecting Tubules.

  • Mechanism: Blocks sodium channels on luminal membranes, excreting sodium and retaining potassium; it is also potassium-sparing.

Potassium Effects

• Hyperkalemia: Can occur from excessive Spironolactone and Amiloride use.

• Hypokalemia: Can result from Lasix (Furosemide) and Thiazides, which promote sodium and water excretion while depleting potassium.

Body Water Volume Changes & Effects

Isosmotic Volume Contraction

• Example: Diarrhea.

• Effect: Loss of fluids and solutes; blood osmolarity does not change;

  • HCT: Increases (same number of RBCs in smaller plasma volume).

  • Protein Concentration: Increases.

Hyperosmotic Volume Contraction

• Example: Sweating, Diabetes Insipidus.

• Effect: Water loss occurs while solutes are retained, increasing plasma osmolarity.

  • HCT: No change (RBCs shrink but ratio remains).

  • Protein Concentration: Increases.

Hypoosmotic Volume Contraction

• Example: Addison’s Disease.

• Effect: Sodium and water are lost, reducing blood osmolarity.

  • HCT: Increases (RBCs swell).

  • Protein Concentration: Increases.

Isosmotic Volume Expansion

• Example: Infusion of isosmotic $NaCl$.

• Effect: Isosmotic fluid added to the plasma compartment.

  • HCT: Decreases.

  • Protein Concentration: Decreases.

Hyperosmotic Volume Expansion

• Example: High $NaCl$ intake, Conn’s disease.

• Effect: Excess aldosterone leads to sodium retention, increasing plasma osmolarity.

  • HCT: Decreases (more plasma volume).

  • Protein Concentration: Decreases.

Hypoosmotic Volume Expansion

• Example: SIADH.

• Effect: Excessive water retention reduces extracellular osmolarity.

  • HCT: No change.

  • Protein Concentration: Decreases.